Biotech company to build facility in China

by World Grain Staff
Share This:
RESEARCH TRIANGLE PARK, NORTH CAROLINA, U.S. — BioResource International, Inc. (BRI) announced on April 12 the signing of a formal agreement to construct a manufacturing facility in China.

BRI has partnered with Taiwan-based Yung Zip Chemical Industrial Co., Ltd. and Yung Shin Pharmaceutical Co., Ltd. to purchase the land and begin construction in Tianmen, a city in Hubei Province, China. The plant will be used to produce BRI’s patented natural feed additives that improve chicken and pig nutrition, thereby lowering costs and reducing waste associated with farming operations.

The decision is a result of the growth in global demand for products such as BRI's Versazyme and Valkerase. The global feed additives market is expected to reach $18 billion by 2015, according to a 2010 report by Global Industry Analysts, Inc.

“We are excited to work with our partners and the government of Tianmen,” said Giles Shih, BRI president and chief executive officer. “This project is a great fit with our three-fold strategic plan of investing in strong global partnerships, environmental sustainability and long-term profitable growth."

The construction and operations of the China manufacturing facility will support economic development for the region and provide immediate economic and environmental benefits for the rapidly growing poultry and swine industry in greater Asia. Moreover, the strategic location in China will allow BRI to be closer to Asian consumers, thereby reducing the carbon footprint and the shipping time involved in delivering products.

Construction is scheduled to begin this summer and the new facility will be operational by the end of 2012. Once complete, the new facility will serve the needs of mainland China, while BRI’s U.S. facility in Apex, North Carolina, U.S., will focus on filling orders across the Americas, Southeast Asia and the Middle East.
Partners